NewList your AI tool for $19 $49. Paste a URL and AI drafts the listing.Submit a tool →Already listed? Claim it free.Claim your tool →

Qure.ai

AI-powered medical imaging analysis for early disease detection and clinical decision support

63KMonthly visits
28Popularity
Qure.ai featured image

About Qure.ai

Qure.ai develops AI solutions for medical imaging analysis, primarily targeting tuberculosis, lung cancer, stroke, and silicosis. Its tools integrate with existing X-ray, CT, and MRI systems to flag abnormalities, measure disease progression, and support triage workflows. The platform is designed to assist clinicians in making faster and more accurate diagnostic and treatment decisions, particularly in resource-constrained settings. It operates across global healthcare networks, including hub-and-spoke models for stroke care and real-time disease surveillance systems. The company emphasizes evidence-based validation, with WHO evaluations and FDA clearances for several products. Typical use cases include screening programs, clinical decision support, and pharmaceutical research acceleration.

Qure.ai Technologies Private Limited (India)

India

Headquarters
India

Key features

  • AI-powered chest X-ray analysis for TB detection
  • Lung nodule detection and progression tracking for lung cancer
  • Stroke care coordination and triage support
  • Silicosis screening and monitoring
  • Real-time disease surveillance systems
  • Integration with existing X-ray, CT, and MRI systems
  • WHO-evaluated and FDA-cleared solutions
  • Hub-and-spoke network support for stroke care

Use cases

  • Screening and early detection of tuberculosis in high-burden regions
  • Lung cancer diagnosis and management in clinical workflows
  • Stroke patient triage and timely intervention in emergency care

Pros

  • WHO-evaluated and FDA-cleared medical imaging AI solutions
  • Supports multiple diseases including tuberculosis, lung cancer, and stroke
  • Integrates with existing imaging hardware and workflows
  • Provides real-time disease surveillance and triage support
  • Validated through real-world studies and clinical partnerships

Cons

  • Limited to medical imaging applications
  • Requires integration with existing healthcare infrastructure
  • Focused on specific diseases rather than general medical AI

Frequently asked questions about Qure.ai

What does Qure.ai do?

Qure.ai develops AI-powered medical imaging analysis solutions for conditions such as tuberculosis, lung cancer, stroke, and silicosis. Its tools integrate with existing X-ray, CT, and MRI systems to flag abnormalities, measure disease progression, and support clinical decision-making.

Who is Qure.ai designed for?

The platform is designed for clinicians, healthcare providers, and public health programs, particularly in resource-constrained settings. It supports triage workflows, screening programs, and real-time disease surveillance across global healthcare networks.

How does Qure.ai integrate with existing healthcare systems?

Qure.ai's AI solutions are designed to fit with both new and old medical imaging hardware, enabling seamless integration with existing X-ray, CT, and MRI systems. This allows for immediate results and streamlined patient referrals.

What evidence supports Qure.ai's effectiveness?

Qure.ai's products have undergone WHO evaluations and received FDA clearances. The company emphasizes evidence-based validation, with real-world studies demonstrating significant impact on diagnostic accuracy and patient outcomes.

Can Qure.ai be used for pharmaceutical research?

Yes, Qure.ai's lung cancer solutions support pharmaceutical research by detecting lung nodules early, measuring disease progression, and managing cases to advance lung health developments.

How can I get started with Qure.ai?

Prospective users can explore Qure.ai's client services and latest developments on their website. The company offers solutions tailored for screening programs, clinical decision support, and public health initiatives.

Qure.ai traffic & engagement

qure.ai · third-party estimates from Similarweb

Data as of Sep 2026Full AI website ranking →
Monthly visits · Sep 202663K+0.9% MoM12-month high 82K (Jul 2026)
Rank among AI websites#2,423▲ 8 vs last monthof 8,652 tools on aitoolnavio™
Rank in Lifestyle & Education#160of 667 tools in this category
Top marketIndia66.1%Top 5 countries bring 85% of visits
Average visit2m 55sLonger than 84% of AI sites
Pages per visit3.64More than 84% of AI sites
Bounce rate33%Lower than 89% of AI sites
Similarweb global rank#461,446#73,418 in India

Traffic trend

Last 4 months · grows by one month every month

  • Jun 202673K
  • Jul 202682K+11.4%
  • Aug 202662K−23.9%
  • Sep 202663K+0.9%

Top countries

Share of visits · estimated visits

  • India42K66.1%
  • United States6.8K10.8%
  • Indonesia2.8K4.4%
  • Australia1.1K1.8%
  • Turkey1K1.6%

Other countries: 15.3%

Visits sent by AI assistants

How people reach this site from other AI tools

380 a month · 0.6% of all visits

  • Gemini24%
  • ChatGPT21.6%

Traffic figures are third-party estimates, good for scale and trends; they can differ from a company's own numbers. Updated monthly.

Reviews